Indegene shines on entering into strategic collaboration with Microsoft
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Indegene is currently trading at Rs. 588.35, up by 18.55 points or 3.26% from its previous closing of Rs. 569.80 on the BSE.
The scrip opened at Rs. 574.10 and has touched a high and low of Rs. 597.25 and Rs. 568.30 respectively. So far 143498 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 659.70 on 13-May-2024 and a 52 week low of Rs. 468.90 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 597.25 and Rs. 540.45 respectively. The current market cap of the company is Rs. 14158.74 crore.
The Institutions and Non-Institutions held 8.55% and 91.46%, stake in the company respectively.
Indegene has entered into strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, thereby driving faster innovation at scale.
Indegene and Microsoft have committed to developing resources in highly specialized and skilled medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.
Indegene’s Enterprise Commercial Solutions primarily involve assisting life sciences companies with their digital marketing operations.
